Literature DB >> 9420267

Mutagenesis of the NS3 protease of dengue virus type 2.

R P Valle1, B Falgout.   

Abstract

The flavivirus protease is composed of two viral proteins, NS2B and NS3. The amino-terminal portion of NS3 contains sequence and structural motifs characteristic of bacterial and cellular trypsin-like proteases. We have undertaken a mutational analysis of the region of NS3 which contains the catalytic serine, five putative substrate binding residues, and several residues that are highly conserved among flavivirus proteases and among all serine proteases. In all, 46 single-amino-acid substitutions were created in a cloned NS2B-NS3 cDNA fragment of dengue virus type 2, and the effect of each mutation on the extent of self-cleavage of the NS2B-NS3 precursor at the NS2B-NS3 junction was assayed in vivo. Twelve mutations almost completely or completely inhibited protease activity, 9 significantly reduced it, 14 decreased cleavage, and 11 yielded wild-type levels of activity. Substitution of alanine at ultraconserved residues abolished NS3 protease activity. Cleavage was also inhibited by substituting some residues that are conserved among flavivirus NS3 proteins. Two (Y150 and G153) of the five putative substrate binding residues could not be replaced by alanine, and only Y150 and N152 could be replaced by a conservative change. The two other putative substrate binding residues, D129 and F130, were more freely substitutable. By analogy with the trypsin model, it was proposed that D129 is located at the bottom of the substrate binding pocket so as to directly interact with the basic amino acid at the substrate cleavage site. Interestingly, we found that significant cleavage activity was displayed by mutants in which D129 was replaced by E, S, or A and that low but detectable protease activity was exhibited by mutants in which D129 was replaced by K, R, or L. Contrary to the proposed model, these results indicate that D129 is not a major determinant of substrate binding and that its interaction with the substrate, if it occurs at all, is not essential. This mutagenesis study provided us with an array of mutations that alter the cleavage efficiency of the dengue virus protease. Mutations that decrease protease activity without abolishing it are candidates for introduction into the dengue virus infectious full-length cDNA clone with the aim of creating potentially attenuated virus stocks.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9420267      PMCID: PMC109416     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  40 in total

1.  Proteolytic processing of a Murray Valley encephalitis virus non-structural polyprotein segment containing the viral proteinase: accumulation of a NS3-4A precursor which requires mature NS3 for efficient processing.

Authors:  M Lobigs
Journal:  J Gen Virol       Date:  1992-09       Impact factor: 3.891

2.  Crystal structure of the hepatitis C virus NS3 protease domain complexed with a synthetic NS4A cofactor peptide.

Authors:  J L Kim; K A Morgenstern; C Lin; T Fox; M D Dwyer; J A Landro; S P Chambers; W Markland; C A Lepre; E T O'Malley; S L Harbeson; C M Rice; M A Murcko; P R Caron; J A Thomson
Journal:  Cell       Date:  1996-10-18       Impact factor: 41.582

3.  Internal proteolysis of the NS3 protein specified by dengue virus 2.

Authors:  K F Teo; P J Wright
Journal:  J Gen Virol       Date:  1997-02       Impact factor: 3.891

4.  Infectious RNA transcripts from full-length dengue virus type 2 cDNA clones made in yeast.

Authors:  S Polo; G Ketner; R Levis; B Falgout
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

5.  Evidence that flavivirus NS1-NS2A cleavage is mediated by a membrane-bound host protease in the endoplasmic reticulum.

Authors:  B Falgout; L Markoff
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

6.  Dengue 2 virus NS2B and NS3 form a stable complex that can cleave NS3 within the helicase domain.

Authors:  C F Arias; F Preugschat; J H Strauss
Journal:  Virology       Date:  1993-04       Impact factor: 3.616

7.  Deletion analysis of dengue virus type 4 nonstructural protein NS2B: identification of a domain required for NS2B-NS3 protease activity.

Authors:  B Falgout; R H Miller; C J Lai
Journal:  J Virol       Date:  1993-04       Impact factor: 5.103

8.  The crystal structure of hepatitis C virus NS3 proteinase reveals a trypsin-like fold and a structural zinc binding site.

Authors:  R A Love; H E Parge; J A Wickersham; Z Hostomsky; N Habuka; E W Moomaw; T Adachi; Z Hostomska
Journal:  Cell       Date:  1996-10-18       Impact factor: 41.582

9.  Japanese encephalitis virus nonstructural protein NS3 has RNA binding and ATPase activities.

Authors:  T Takegami; D Sakamuro; T Furukawa
Journal:  Virus Genes       Date:  1995-01       Impact factor: 2.332

10.  Mutagenesis of the yellow fever virus NS2A/2B cleavage site: effects on proteolytic processing, viral replication, and evidence for alternative processing of the NS2A protein.

Authors:  A Nestorowicz; T J Chambers; C M Rice
Journal:  Virology       Date:  1994-02-15       Impact factor: 3.616

View more
  21 in total

Review 1.  Perspectives for the treatment of infections with Flaviviridae.

Authors:  P Leyssen; E De Clercq; J Neyts
Journal:  Clin Microbiol Rev       Date:  2000-01       Impact factor: 26.132

2.  Langat flavivirus protease NS3 binds caspase-8 and induces apoptosis.

Authors:  Grigori G Prikhod'ko; Elena A Prikhod'ko; Alexander G Pletnev; Jeffrey I Cohen
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

3.  Structural and functional parameters of the flaviviral protease: a promising antiviral drug target.

Authors:  Sergey A Shiryaev; Alex Y Strongin
Journal:  Future Virol       Date:  2010-09-01       Impact factor: 1.831

4.  C-terminal residue optimization and fragment merging: discovery of a potent Peptide-hybrid inhibitor of dengue protease.

Authors:  Mira A M Behnam; Christoph Nitsche; Sérgio M Vechi; Christian D Klein
Journal:  ACS Med Chem Lett       Date:  2014-07-18       Impact factor: 4.345

5.  Chemical mutagenesis of dengue virus type 4 yields mutant viruses which are temperature sensitive in vero cells or human liver cells and attenuated in mice.

Authors:  J E Blaney; D H Johnson; C Y Firestone; C T Hanson; B R Murphy; S S Whitehead
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

6.  Enzymatic characterization of a trypsin-like serine protease encoded by the genome of cell fusing agent virus.

Authors:  Christophe N Peyrefitte; Boris A M Pastorino; Marc Grandadam; Dominique Rolland; Hugues J Tolou; Maël Bessaud
Journal:  Virus Genes       Date:  2006-12-02       Impact factor: 2.332

Review 7.  Organization of the Flavivirus RNA replicase complex.

Authors:  Carolin Brand; Martin Bisaillon; Brian J Geiss
Journal:  Wiley Interdiscip Rev RNA       Date:  2017-08-16       Impact factor: 9.957

8.  Phylogeography and molecular epidemiology of an epidemic strain of dengue virus type 1 in Sri Lanka.

Authors:  Karen E Ocwieja; Anira N Fernando; Scott Sherrill-Mix; Sesh A Sundararaman; Rashika N Tennekoon; Rashmi Tippalagama; Shivankari Krishnananthasivam; Gayani Premawansa; Sunil Premawansa; Aruna Dharshan De Silva
Journal:  Am J Trop Med Hyg       Date:  2014-05-05       Impact factor: 2.345

9.  Identification of new potent inhibitors of dengue virus NS3 protease from traditional Chinese medicine database.

Authors:  Vivek Dhar Dwivedi; Indra Prasad Tripathi; Shiv Bharadwaj; Aman Chandra Kaushik; Sarad Kumar Mishra
Journal:  Virusdisease       Date:  2016-07-20

10.  Mechanism of NS2B-mediated activation of NS3pro in dengue virus: molecular dynamics simulations and bioassays.

Authors:  Zhili Zuo; Oi Wah Liew; Gang Chen; Pek Ching Jenny Chong; Siew Hui Lee; Kaixian Chen; Hualiang Jiang; Chum Mok Puah; Weiliang Zhu
Journal:  J Virol       Date:  2008-10-29       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.